Indian drug manufacturer Neuland Labs slumps on Q3 results

Neuland Laboratories

11/02/2025 04:16

** India's Neuland Laboratories  NEUL.NS  down 6.04% at
13,782 rupees after Q3 results
    ** Stock set for worst day since Nov. 6 when it reported Q2
results
    ** Bulk drug manufacturer's Q3 core profit declines by 26.4%
y/y, while revenue increases less than 2%
    ** Stock has more than doubled in value in the last 12
months

 (Reporting by Ananta Agarwal in Bengaluru)
 ((Ananta.Agarwal@thomsonreuters.com))